Navigation Links
Positive results from phase 1 clinical trials of cuprindro
Date:2/15/2008

Medical Therapies Limited today announced that it has completed its first in human clinical trial of Cuprindo™ with interim results from patient diaries indicating that Cuprindo™ is safe and well tolerated.

The trial subjects, healthy volunteers, reported 100% compliance with the dosing protocol which involved application of Cuprindo™ suppositories twice daily over a seven day period. In addition, post-trial colonoscopy on the subjects uncovered healthy mucosa and no evidence of rectal inflammation or ulceration.

The safety trial was conducted in preparation for a planned efficacy study in proctitis patients.

The trial has been a success confirming our pre-clinical safety information on Cuprindo™ and it paves the way for our efficacy study in patients with proctitis, said Medical Therapies Chief Executive Officer Maria Halasz.

While the trial was not geared to assess Cuprindo™s systemic efficacy, one subject reported relief in chronic joint pain after Day 4 of the trial. Results of the full biochemical analysis of the trial assays including information on systemic absorption characteristics of Cuprindo™ are expected in the coming weeks.

Proctitis is a debilitating disease characterised by inflammation and ulceration of the colon, resulting in tiny open sores that can bleed and produce mucus. Symptoms of the disease include chronic diarrhoea, bloody stools and, in severe cases, faecal incontinence.

Current treatments such as corticosteroids and immuno-modulators can cause serious side effects and provide no relief for up to 30% of proctitis patients. A topically applied safe treatment, such as a Cuprindo™ suppository, could provide a much needed alternative for the 1 in 60 people suffering from the disease.


'/>"/>

Contact: Dr. Stephanie Williams
williams@medicaltherapies.com.au
61-292-990-311
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive
2. HPV-positive head and neck cancer patients fare better than HPV-negative patients
3. HPV-Positive Head and Neck Cancers Fare Better
4. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
5. Seeing our spouses more negatively might be a positive
6. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
7. Eating out can have both positive and negative impact on obesity
8. Medco CEO Reiterates Guidance, Positive Outlook for 2008
9. Brain Turns to Positive Thoughts When Faced With Death
10. Anthracyclines improve survival in HER2-positive breast cancer patients
11. Six Positive Predictions for 2008, from SuperLife World Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief ... advancements to physician colleagues, skilled nursing facility medical directors and other clinicians at ... of Wound Care." , "At many of these conferences we get to educate ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 /PRNewswire/ ... and OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... a strategic hub service that expedites and streamlines patient ... spirometer, Spiro PD 2.0, and wellness management services.  ... a medical device used to measure lung function for ...
Breaking Medicine Technology: